Abstract Submission Deadline: January
Participant Abstracts and Young
Investigator Abstracts must be submitted on-line. Abstracts that are
selected will be presented either orally or in a poster format. All
abstracts selected will be formatted for the scientific program which will
be distributed at the meeting.
conference invitees are invited to submit abstracts. Abstracts submitted
before the deadline are reviewed, judged and scored by an international
review committee. Based on overall scores, participant abstract submissions
will be selected for either an oral or poster presentation. Please note, for
abstracts that are selected for oral presentations the same person
submitting the abstract must present the abstract.
IAC Young Investigator
Abstract Competition and Award
purpose of the IAC Young Investigator Award is to recognize young
investigators with research in basic and/or clinical studies relevant to
aldosterone and mineralocorticoid receptor biology.
Eligibility for the IAC Young Investigator Competition and Awards is
confined to students and fellows with up to 5 years postdoctoral research experience,
exclusive of clinical training, at
the time the abstract is submitted. Previous finalists for the award may not
participate. Each applicant must be nominated by their research mentor,
limit one nominee per mentor.
Abstracts will be reviewed, judged and chosen by an international review
will be judged on their scientific uniqueness, the quality of the hypothesis
being tested and adherence to the primary goal of the award. Four abstracts
will be chosen for the competition section of the scientific program and
will be printed in the program book.
Travel awards will be presented to each of the chosen young investigator
finalists. The first place winner will receive $1,000 USD. Each runner-up
will receive $500 USD. Each participant will be presented with an award
plaque. Each finalist will be responsible for securing their own hotel
accommodations and travel.
The entire abstract, including title, author(s), affiliation(s), city and
state, text, graphics and/or tables, must fit on an 11 x 8.5" sheet of
paper with 1" margins all around.
As a majority of word processor's have a default margin of 1.5 inches, it
may be necessary for you to manually set your margin size. Please confirm 1"
margins on your document prior to submitting.
and Font Size:
Arial 11 pt.
spacing and normal headings throughout. Use left justification
only. Do NOT use tab sets. Do NOT indent. Use hard returns only for
paragraph spacing options. Do NOT place your abstract in a text box or apply
a border of any type.
Do NOT submit an abstract with the “Track Changes”
feature turned on.
The title should be brief, clearly indicating the nature of the
presentation. It should appear in title case (not all caps or lower case),
bolded and italicized.
List all author's names and institutions. Underline the presenting
author’s name and institution only.
Acknowledgements of grant support or funding may be provided at the end of
State the purpose of the study (preferably in one sentence). State methods
used. Summarize results presented in sufficient detail to support the
conclusions. State the conclusions reached. (It is not satisfactory to say,
“The results will be discussed"). Include tables or images only if they are
simple, neat, and fit within the allowed size limits. You may include both a
table and an image but no more than one of each. Use standard abbreviations,
e.g., RBC. Use kg., gm., mg., ml., L. (liter), mEQ.,M (meter), and %
(percent). Place a special or unusual abbreviation in parentheses after the
full word, the first time it appears. Use numerals to indicate numbers,
except to begin sentences. Non-proprietary (generic) names of drugs should
The preferred file format is MicroSoft Word. PDF files are not acceptable.
Select an abstract category theme by clicking on the category of your
choice. Only one category may be selected.
Abstract Acceptance Notification.
You will receive an abstract status notification via email no later than
February 4th to inform you if your abstract has been accepted for an oral
or poster presentation. The program planning committee cannot respond to any abstract
status inquiries prior to this date. It is the responsibility of the
presenting author to contact other authors about the status of the abstract.
A presenting author must be designated for each abstract. The presenting
author is responsible for giving the oral and/or poster presentation, if the
abstract is accepted. Presenting authors should speak and answer questions
You may submit as many abstracts as you wish. Each abstract requires an
individual submission. DO NOT attach more than one abstract at a time to an
email submission. The program planning committee will consider the total
number of abstracts submitted by the same author when developing the
Abstract submissions may be withdrawn anytime before and up to February 4th.
Changes to Submitted Abstracts.
If you must make a change to your submitted abstracts, contact
Roxanne Hall by email at
edits may be made after the abstract deadline date.
Abstract Receipt Confirmation.
by email if you do not receive an e-mail or fax confirmation within 48
hours (2 days) of submitting your abstract. Lack of confirmation
indicates that your abstract was not received.
Submit your abstract by January 4, 2019. Abstracts received after the
deadline will not be
considered for oral presentations or the
Young Investigator Competition.
here to register your abstract.
Complete the form and click on the submit button. (all fields are required)
your form is submitted you will immediately receive a confirmation on the
Submit your abstract by attaching it to an email and typing in the Subject
line either Participant or Young Investigator. Email to
email@example.com. In the body of the
email message include the submitter's name and all contact information.
Investigator submissions must also include the nominating participant's name
and contact information and the Young Investigator's name and contact